Pharmacodynamic effects and pharmacokinetics of a new HMG-CoA reductase inhibitor, rosuvastatin, after morning or evening administration in healthy volunteers

Por Martin, Paul D, Mitchell, Patrick D, Schneck, Dennis W
Publicado em 2002

Hypoxemia in patients with COPD: cause, effects, and disease progression

Por Kent, Brian D, Mitchell, Patrick D, McNicholas, Walter T
Publicado em 2011

The effect of rosuvastatin on oestrogen & progestin pharmacokinetics in healthy women taking an oral contraceptive

Por Simonson, Steven G, Martin, Paul D, Warwick, Mike J, Mitchell, Patrick D, Schneck, Dennis W
Publicado em 2004

Therapeutic interventions in severe asthma

Por Canonica, Giorgio Walter, Senna, Gianenrico, Mitchell, Patrick D., O’Byrne, Paul M., Passalacqua, Giovanni, Varricchi, Gilda
Publicado no World Allergy Organ J (2016)

IL-25 and IL-33 induce Type 2 inflammation in basophils from subjects with allergic asthma

Por Salter, Brittany M., Oliveria, John Paul, Nusca, Graeme, Smith, Steve G., Tworek, Damian, Mitchell, Patrick D., Watson, Rick M., Sehmi, Roma, Gauvreau, Gail M.
Publicado no Respir Res (2016)